Bio-Techne (TECH) Tops Q4 EPS by 1c

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $117.7 million versus the consensus estimate of $116.85 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49